Your browser doesn't support javascript.
loading
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression.
Filippone, A; Lanza, M; Mannino, D; Raciti, G; Colarossi, C; Sciacca, D; Cuzzocrea, S; Paterniti, I.
Afiliación
  • Filippone A; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Lanza M; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Mannino D; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Raciti G; IOM Ricerca Srl, via Penninazzo 11, 95029, Catania, Italy.
  • Colarossi C; Instituto Oncologico del Mediterraneo, via Penninazzo 7, 95029, Catania, Italy.
  • Sciacca D; Instituto Oncologico del Mediterraneo, via Penninazzo 7, 95029, Catania, Italy.
  • Cuzzocrea S; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Paterniti I; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy. ipaterniti@unime.it.
Cancer Immunol Immunother ; 71(9): 2067-2075, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35092481

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Proteínas de Punto de Control Inmunitario Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Proteínas de Punto de Control Inmunitario Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Italia